Skip to content
MARKETS / COMPARE / NBIX VS QGEN

NBIX vs QGEN

Neurocrine Biosciences Inc. and Qiagen N.v., side by side — 10 fiscal years reported in USD, drawn from SEC filings.

At a glance

Most recent reported year

NBIX vs QGEN, at a glance
Metric NBIX QGEN
Revenue$2.9B$2.1B
Net income$478.6M$424.9M
Gross margin98.2%62.2%
Net margin16.7%20.3%
Return on equity16.4%11.6%
Diluted EPS$4.67$1.94
Dividend / share·$0.25
Payout ratio·12.8%
Free cash flow$748.7M$453.3M
Equity$3.3B$3.8B
Net debt / equity·0.22×
Current ratio3.39×3.90×
Revenue CAGR 5y22.3%2.2%
Profit CAGR 5y3.3%3.4%

NBIX bills 1.4× the revenue of QGEN, and QGEN keeps more of each dollar of revenue as profit (20.3% against 16.7%).

The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.

Revenue by year

10 years side by side

NBIX vs QGEN, revenue by year
Fiscal year NBIX QGEN
FY2025$2.9B$2.1B
FY2024$2.4B$2.0B
FY2023$1.9B$2.0B
FY2022$1.5B$2.1B
FY2021$1.1B$2.3B
FY2020$1.0B$1.9B
FY2019$788.1M$1.5B
FY2018$451.2M$1.5B
FY2017$161.6M$1.4B
FY2016$15.0M$1.3B
Net income by year

Bottom line

NBIX vs QGEN, net income by year
Fiscal year NBIX QGEN
FY2025$478.6M$424.9M
FY2024$341.3M$83.6M
FY2023$249.7M$341.3M
FY2022$154.5M$423.2M
FY2021$89.6M$512.6M
FY2020$407.3M$359.2M
FY2019$37.0M$-41.5M
FY2018$21.1M$190.4M
FY2017$-142.5M$40.4M
FY2016$-141.1M$80.4M
Revenue gap over time

17 fiscal years

Revenue gap over time
Fiscal year Difference Ahead
FY2025+$770,501,000NBIX
FY2024+$377,086,000NBIX
FY2023−$78,211,000QGEN
FY2022−$652,818,000QGEN
FY2021−$1,118,157,000QGEN
FY2020−$824,446,000QGEN
FY2019−$738,324,000QGEN
FY2018−$1,050,648,000QGEN
FY2017−$1,255,910,000QGEN
FY2016−$1,322,991,000QGEN
FY2015−$1,261,217,000QGEN
FY2014−$1,344,777,000QGEN
FY2013−$1,299,065,000QGEN
FY2012−$1,201,316,000QGEN
FY2011−$1,092,334,000QGEN
FY2010−$1,053,930,000QGEN
FY2009−$1,006,872,000QGEN

The higher-revenue side has changed between NBIX and QGEN over this period. The gap has narrowed since the earliest year compared.

17 of 18 comparable fiscal years — a year missing data on either side is not counted.

Net margin gap over time

14 fiscal years

Net margin gap over time
Fiscal year Difference Ahead
FY2025−3.6 ppQGEN
FY2024+10.3 ppNBIX
FY2023−4.1 ppQGEN
FY2022−9.4 ppQGEN
FY2021−14.9 ppQGEN
FY2020+19.7 ppNBIX
FY2019+7.4 ppNBIX
FY2018−8.0 ppQGEN
FY2017−91.0 ppQGEN
FY2016−946.6 ppQGEN
FY2015−460.0 ppQGEN
FY2012−0.9 ppQGEN
FY2011+40.4 ppNBIX
FY2010−37.1 ppQGEN

The higher net margin has changed hands between NBIX and QGEN over this period.

14 of 18 comparable fiscal years — a year missing data on either side is not counted.

Net margin volatility

Standard deviation, each side

NBIX's net margin has been more volatile than QGEN's over the 14 comparable fiscal years — 263.7 percentage points of standard deviation against 7.3.

14 of 18 comparable fiscal years — a year missing data on either side is not counted.

Who led in net margin

Year by year

The lead in net margin changed hands between NBIX and QGEN over these 14 fiscal years — NBIX led in 4 and QGEN in 10.

14 of 18 comparable fiscal years — a year missing data on either side is not counted.

Return on equity volatility

Standard deviation, each side

NBIX's return on equity has been more volatile than QGEN's over the 17 comparable fiscal years — 305.5 percentage points of standard deviation against 4.8.

17 of 18 comparable fiscal years — a year missing data on either side is not counted.

Who led in return on equity

Year by year

The lead in return on equity changed hands between NBIX and QGEN over these 17 fiscal years — NBIX led in 6 and QGEN in 11.

17 of 18 comparable fiscal years — a year missing data on either side is not counted.

More in this industry

Other pairs

The companies

Full pages